USE OF PIPERAZINE SULFONIC ACID DERIVATIVES AS CCR1 ANTAGONISTS FOR THE TREATMENT OF FIBROSIS, ALZHEIMER DISEASE AND OTHER DISORDERS

Details for Australian Patent Application No. 2003269381 (hide)

Owner PFIZER PRODUCTS INC.

Inventors Gaweco, Anderson See; Gladue, Ronald Paul; Hayward, Matthew Merrill; Brown, Matthew Frank

Agent Spruson & Ferguson

Pub. Number AU-A-2003269381

PCT Number PCT/IB03/04642

PCT Pub. Number WO2004/039377

Priority 60/422,573 30.10.02 US

Filing date 20 October 2003

Wipo publication date 25 May 2004

International Classifications

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 025/18 Drugs for disorders of the nervous system

A61P 031/12 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 025/00 Drugs for disorders of the nervous system

Event Publications

15 January 2004 Complete Application Filed

  Priority application(s): 60/422,573 30.10.02 US

24 June 2004 Application Open to Public Inspection

  Published as AU-A-2003269381

7 June 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003269382-A SIMPLE APPARATUS FOR PREPARING EXPERIMENTAL MODELS OF BRAIN NEURONAL DAMAGE AND PREPARATION OF SECONDARY BRAIN DAMAGE MODEL WITH METHODS FOR EVALUATION OF DRUG EFFICACY OF NOVEL COMPOUNDS AGAINST BRAIN DAMAGE AND MEMORY-RELATED EVENTS

2003269380-QUINUCLIDINIUM DERIVATIVES AS ANTIMUSCARINIC AGENTS